Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cognitive Impairments Associated With Schizophrenia”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Testing effectiveness (Phase 2)Study completedNCT01911676
What this trial is testing

Translational Neuroscience Optimization of GlyT1 Inhibitor

Who this might be right for
Cognitive Impairments Associated With Schizophrenia
Yale University 71
Early research (Phase 1)Study completedNCT02332798
What this trial is testing

Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia

Who this might be right for
Schizophrenia
Biogen 39
Not applicableStudy completedNCT07137572
What this trial is testing

Arts-based Social Prescribing for Mental Health

Who this might be right for
Mental Health IssueAnxiety DisordersAffective Disorders+7 more
KAVADIA ELENI 541
Testing effectiveness (Phase 2)Study completedNCT00487942
What this trial is testing

Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits

Who this might be right for
Schizophrenia
Cephalon 60
Testing effectiveness (Phase 2)Study completedNCT01266174
What this trial is testing

Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults

Who this might be right for
Cognitive ImpairmentSchizophrenia
Amarantus BioScience Holdings, Inc. 31
Not applicableLooking for participantsNCT05445180
What this trial is testing

Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use

Who this might be right for
Psychotic DisordersCannabis Use DisorderCannabis Dependence+5 more
Douglas Mental Health University Institute 134
Not applicableNot Yet RecruitingNCT07446478
What this trial is testing

TIS for Improving Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Cognitive Impairment Associated With Schizophrenia (CIAS)
Central South University 10
Very early researchEnded earlyNCT01813955
What this trial is testing

Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia

Who this might be right for
SchizophreniaCognitive Deficits
University of Copenhagen 5
Testing effectiveness (Phase 2)UnknownNCT00604760
What this trial is testing

Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Cognitive Impairment Associated With Schizophrenia
Memory Pharmaceuticals 160
Early research (Phase 1)Study completedNCT01959594
What this trial is testing

Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult Volunteers

Who this might be right for
Healthy
Pfizer 40
Testing effectiveness (Phase 2)Study completedNCT05686239
What this trial is testing

Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)

Who this might be right for
Cognitive Impairment Associated With Schizophrenia (CIAS)Cognitive ImpairmentSchizophrenia
Recognify Life Sciences 242
Testing effectiveness (Phase 2)Looking for participantsNCT07191483
What this trial is testing

Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Cognitive Impairment Associated With Schizophrenia (CIAS)
Kynexis B.V. 150
Testing effectiveness (Phase 2)Ended earlyNCT01874756
What this trial is testing

The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Schizophrenia
Indiana University 95
Early research (Phase 1)Study completedNCT04972227
What this trial is testing

Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia

Who this might be right for
Schizophrenia
Tisento Therapeutics 48
Testing effectiveness (Phase 2)Ended earlyNCT05182476
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Schizophrenia
Neurocrine Biosciences 216
Not applicableNot Yet RecruitingNCT05440955
What this trial is testing

TDCS for Cognitive Impairment Associated With Recent-onset Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorder
University Hospital, Grenoble 60
Testing effectiveness (Phase 2)Study completedNCT03745820
What this trial is testing

Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

Who this might be right for
Cognitive Impairment Associated With Schizophrenia
Biogen 195
Testing effectiveness (Phase 2)Ended earlyNCT02855411
What this trial is testing

Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)

Who this might be right for
Cognitive Impairment Associated With Schizophrenia (CIAS)
Biogen 35
Early research (Phase 1)Study completedNCT02228395
What this trial is testing

Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers

Who this might be right for
Healthy
Biogen 12
Large-scale testing (Phase 3)Study completedNCT00077727
What this trial is testing

The Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 107
Load More Results